DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia

View Full Size 

Download

• Full Size JPEG, 818x258, 111.7 KB
• Small JPEG, 480x151, 58.1 KB
• Preview JPEG, 144x45, 9.9 KB
• Thumbnail JPEG, 120x38, 7.3 KB